Recruiting trials No registered studies found for Jung syndrome. ClinicalTrials.gov has no study listed under this name as of 7 Sept 2026. That can change, and there are other routes worth knowing about.
Keep watching
Get an email when a new Jung syndrome study opens. One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy .
Support
Patient organisations We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Jung syndrome RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.
Treatments being studied 63 approved treatments and 86 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Approved: Sulfacetamide Sodium (Albucid) Approved: Prednisolone Acetate (Econopred) Approved: Choline Salicylate (Dinnefords) Approved: Loteprednol Etabonate (Alrex) Approved: Prednicarbate (Dermatop) Approved: Betamethasone Butyrate Propionate Approved: Lidocaine (Alphacaine) Approved: Desoximetasone (Desoximetasone) Approved: Lamivudine (Epivir) Approved: Diclofenac (Voltaren ophthalmic) Approved: Fluocinolone Acetonide (Capex) Approved: Halobetasol Propionate (Bryhali) Approved: Chloroxylenol Approved: Pramoxine Hydrochloride (Pramoxine hydrochloride component of epifoam) Approved: Aescin Approved: Benzocaine (Aezodent) Approved: Fluorometholone (Fluaton) Approved: Tobramycin (Aktob) Approved: Betamethasone Benzoate (Uticort) Approved: Dexamethasone (Aeroseb-dex) Approved: Nepafenac (Ilevro) Approved: Droxicam Approved: Hydrocortisone (Acetasol hc) Approved: Prednisone (Cortan) Approved: Certolizumab Pegol (Cimzia) Approved: Gentamicin Sulfate (Apogen) Approved: Interferon Gamma-1b (Actimmune) Approved: Bromfenac Approved: Natalizumab (Natalizumab elan pharma) Approved: Camphor Approved: Loxoprofen Approved: Halometasone Approved: Amtolmetin Guacil Approved: Ampiroxicam Approved: Acetic Acid (Acetasol) Approved: Phenylephrine Hydrochloride (Afrin 4 hour nasal spray) Approved: Bromfenac Sodium (Bromday) Approved: Flurandrenolide (Cordran) Approved: Celecoxib (Celebra) Approved: Apazone (Rheumox) Approved: Difluprednate (Durezol) Approved: Fluocinonide (Fluocinonide) Approved: Paramethasone Approved: Amcinonide (Amcinonide) Approved: Cyclosporine (Capimune) Approved: Aceclofenac (Gerbin) Approved: Neomycin Sulfate (Biomydrin) Approved: Dexamethasone Sodium Phosphate (Ak-dex) Approved: Polymyxin B Sulfate (Aerosporin) Approved: Imidazole Salicylate Approved: Hydrocortamate Approved: Hydrocortisone Acetate (Barquinol hc) Approved: Betamethasone (Betasolan) Approved: Alclometasone Approved: Prednisolone Sodium Phosphate (Codelsol) Approved: Methylprednisolone (Medrol) Approved: Penicillamine (Cuprimine) Approved: Salicylic Acid (Acnisal) Approved: Esflurbiprofen Approved: Ketorolac Tromethamine (Acular) Approved: Benoxaprofen (Oraflex) Approved: Bacitracin Zinc (Bacitracin zinc component of cortisporin) Approved: Guaimesal
Phase 3 Tilnoprofen Arbamel
Phase 3 Histamine
Phase 3 Icosapent
Phase 3 Azithromycin (Azasite)
Phase 3 Naphazoline Hydrochloride (Albalon)
Phase 3 Methotrexate (Ebetrex)
Phase 3 Ketorolac
Phase 3 Atorvastatin (Cardyl)
+ 78 more in development
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).